BetaCell Podcast: Recent Episodes
Beta Cells in Diabetes
The Beta Cells in Diabetes podcast seeks to improve understanding among primary care physicians about the role of beta cells as key drivers in the development and progression of T2DM. Our goal is to engage primary care physicians in pathopysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their patient treatment regimens. By educating primary care physicians about the newest findings regarding beta cell treatment, we hope to positively affect the diabetes epidemic.
Dr. Doron Schneider and Dr. Jack Leahy discuss what The Diabetes Control and Complications discovered about weight issues and the Diabetic patient.
Dr. Doron Schneider and Dr. Jack Leahy discuss what the DCCT and EDIC trials found regarding type 2 diabetes.
Dr. Schneider and Dr. Leahy discuss the surprising result of "metabolic memory" from the findings of the DCCT and EDIC trials.
Dr. Schneider and Dr. Leahy, discuss the findings of the DCCT and EDIC studies as they relate to the impact of tight control of diabetes in the early stages of the disease.
Dr. Schneider and Dr. Leahy discuss EDIC, the follow up study to The Diabetes Control and Complications trial.
Dr. Doron Schneider and Dr. Jack Leahy discuss The Diabetes and Complications Trial, a landmark study that still influences the standard of diabetes patient care.
Dr. Doron Schneider and Dr. Jack Leahy discuss the Diabetes Control and Complications Trial and the follow up study, EDIC. These landmark, studies performed 30 years ago, have stood the test of time and still influences the standard of care today.
Doron Schneider, MD and Jack Leahy, MD discuss the effectiveness and challenges of bariatric surgery. (7:18)
Doron Schneider, MD and Jack Leahy, MD discuss the importance of patient BMI and other risk factors for coronary artery disease when weighing treatment options. (12:08)
Doron Schneider, MD and Jack Leahy, MD discuss the pros and cons of combination therapy for as initial treatment. (17:40)